Creative Medical Technology
CELZ
12 hedge funds and large institutions have $233K invested in Creative Medical Technology in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
26% more capital invested
Capital invested by funds: $185K → $233K (+$48K)
0.04% more ownership
Funds ownership: 2.71% → 2.74% (+0.04%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$46.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.38K |
| 4 |
Jones Financial Companies
Des Peres,
Missouri
|
+$3.1K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$620 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$31K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$29.5K |
| 3 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
-$6.03K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.73K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6 |
CELZ Hedge Fund Activity: Q3 2025 in Review
12 of the 7,635 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q3 2025, worth a combined $233K — up 26% from $185K a quarter earlier.
Fund positioning in CELZ was balanced in Q3 2025: 4 funds opened new positions, 4 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $46.8K. The largest seller was Northern Trust, exiting entirely with an estimated $31K sold.
- 12 institutional investors held Creative Medical Technology (CELZ) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $233K of Creative Medical Technology stock for Q3 2025, up 26% quarter-over-quarter.
- 4 funds opened new Creative Medical Technology positions in Q3 2025 and 4 closed out, a net change of 0 holders.
- The largest Creative Medical Technology buyer in Q3 2025 was DRW Securities, an estimated $46.8K added.
- The largest Creative Medical Technology seller in Q3 2025 was Northern Trust, an estimated $31K sold.
Based on aggregated 13F filings for Q3 2025.